The ELI5 antibody (Product Code: CSB-PA851407XA01DOA) is a custom monoclonal antibody produced by Cusabio. Key identifiers include:
| Parameter | Description |
|---|---|
| Target Protein | ELI5 (UniProt ID: Q8RY79) |
| Species Reactivity | Arabidopsis thaliana (Mouse-ear cress) |
| Applications | Western Blot (WB), Immunohistochemistry (IHC), ELISA |
| Available Sizes | 2 mL or 0.1 mL |
This antibody is part of a specialized collection of rare antibodies developed for plant research .
ELI5 (Early Light-Induced Protein 5) is a nuclear-encoded protein implicated in plant stress responses, particularly under high-light conditions. While the exact mechanistic role of ELI5 remains under investigation, homologs in Arabidopsis are associated with:
Chloroplast function: Regulation of photosynthetic machinery during abiotic stress .
DNA repair: Interaction with proteins involved in maintaining genomic stability .
The UniProt entry for Q8RY79 classifies ELI5 as a member of the DnaJ-like protein family, which typically functions as molecular chaperones .
The ELI5 antibody is optimized for use in:
Western Blot: Detecting ELI5 expression levels in Arabidopsis leaf extracts under stress conditions.
Immunohistochemistry: Localizing ELI5 within chloroplasts and nuclei .
Specificity: Validated using knockout (KO) Arabidopsis lines to confirm absence of cross-reactivity .
Reproducibility: Batch-to-batch consistency ensured through recombinant antibody technology .
Recombinant Antibodies: The ELI5 antibody aligns with industry shifts toward recombinant antibodies, which show higher specificity and reproducibility compared to polyclonal counterparts .
High-Throughput Screening: Platforms like LIBRA-seq enable rapid identification of antibodies targeting specific epitopes, as seen in viral research .
Low Commercial Availability: Only ~12% of plant proteins have commercially available antibodies, making tools like the ELI5 antibody critical for niche studies .
Epitope Conservation: Plant proteins often share epitopes across species, necessitating rigorous validation to avoid off-target binding .
The ELI5 antibody is available through Cusabio’s Custom Antibodies project, which focuses on rare targets in plant biology . Researchers are advised to:
Use KO controls to validate specificity in Arabidopsis experiments .
Optimize protocols for chloroplast lysis when working with photosynthetic tissues .
While no direct studies on ELI5’s functional role were identified in the reviewed literature, its homology to stress-response proteins suggests potential research avenues:
Antibody research encompasses diverse methodologies from basic immunological principles to advanced computational modeling. Below is a structured FAQ addressing key academic research challenges, experimental designs, and data interpretation strategies, synthesized from peer-reviewed studies and technical innovations.
Hybrid immunity studies reveal antibodies recognizing conserved epitopes across sarbecoviruses. For example:
| Antibody | Neutralization Breadth (Viruses) | Key Epitope |
|---|---|---|
| CC25.36 | SARS-CoV-2, SARS-CoV-1, SHC014 | RBD subdomain 1 |
| CC25.53 | 5 SARS-CoV-2 variants, pangolin CoV | RBD glycan shield |
B cell sorting: Isolate memory B cells from donors with hybrid immunity.
Deep mutational scanning: Map escape mutations to identify evolutionarily constrained epitopes .
The AbMap framework combines:
Language models trained on 3,000+ antibody structures for hypervariable loop modeling.
Affinity prediction modules correlating sequences with antigen-binding strength.
| Model | Accuracy (RMSD) | Binding Affinity Prediction (R²) |
|---|---|---|
| AbMap | 1.2 Å | 0.87 |
| AlphaFold-Multimer | 2.8 Å | 0.62 |
Generate antibody variants via directed evolution.
Cluster candidates by structural similarity.
Microfluidic proteolysis probes conformational flexibility:
Flow cells: Immobilize target proteins under physiological shear stress.
Protease gradients: Titrate trypsin/chymotrypsin to identify protease-resistant epitopes.
MS/MS analysis: Map cleavage sites to guide affinity maturation .
Case study: Antibodies targeting cryptic epitopes on Cyclin-dependent kinase inhibitor 2A showed 5× improved half-life after kinetic optimization .
| Factor | In Vitro Bias | In Vivo Consideration |
|---|---|---|
| Epitope accessibility | Static binding assays | Tissue penetration, target density |
| Fc-mediated effects | Neutralization-only readouts | ADCC, CDC, phagocytosis |